Literature DB >> 11239920

GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine.

M R Gerasimov1, W K Schiffer, E L Gardner, D A Marsteller, I C Lennon, S J Taylor, J D Brodie, C R Ashby, S L Dewey.   

Abstract

Environments previously associated with drug use can become one of the most common factors triggering relapse to drug-seeking behavior. To better understand the neurochemical mechanisms potentially mediating these cues, we measured nucleus accumbens dopamine levels in animals exposed to environmental cues previously paired with cocaine administration. In animals exposed to a cocaine-paired environment nucleus accumbens dopamine increased by 25%. When administered 2.5 h prior to presentation of the environmental trigger, racemic vigabatrin (an irreversible inhibitor of gamma-aminobutyric acid (GABA)-transaminase) abolished this cue-induced increase. Conversely, R-(-)-vigabatrin, the inactive enantiomer, had no effect. Combined with our earlier findings, these studies support the potential therapeutic benefit of this enzyme-based GABAergic strategy to modulate brain dopamine and the subsequent treatment of drug addiction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239920     DOI: 10.1016/s0014-2999(01)00800-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

Review 1.  Brain circuitry and the reinstatement of cocaine-seeking behavior.

Authors:  Peter W Kalivas; Krista McFarland
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

2.  Modelling the risk of visual field loss arising from long-term exposure to the antiepileptic drug vigabatrin: a cross-sectional approach.

Authors:  John M Wild; David L Fone; Saleh Aljarudi; Charlotte Lawthom; Philip E M Smith; Robert G Newcombe; Gareth D Lewis
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749

Review 3.  The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.

Authors:  Christian A Heidbreder; Eliot L Gardner; Zheng-Xiong Xi; Panayotis K Thanos; Manolo Mugnaini; Jim J Hagan; Charles R Ashby
Journal:  Brain Res Brain Res Rev       Date:  2005-07

4.  Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction.

Authors:  Karyn M Myers; William A Carlezon
Journal:  Neurosci Biobehav Rev       Date:  2010-01-28       Impact factor: 8.989

5.  Use of animal models to develop antiaddiction medications.

Authors:  Eliot L Gardner
Journal:  Curr Psychiatry Rep       Date:  2008-10       Impact factor: 5.285

6.  Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues.

Authors:  Kimberly A Young; Teresa R Franklin; David C S Roberts; Kanchana Jagannathan; Jesse J Suh; Reagan R Wetherill; Ze Wang; Kyle M Kampman; Charles P O'Brien; Anna Rose Childress
Journal:  J Neurosci       Date:  2014-04-02       Impact factor: 6.167

Review 7.  Novel approaches to the treatment of cocaine addiction.

Authors:  Mehmet Sofuoglu; Thomas R Kosten
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

8.  Dynamic changes of tyrosine hydroxylase and dopamine concentrations in the ventral tegmental area-nucleus accumbens projection during the expression of morphine-induced conditioned place preference in rats.

Authors:  Jing Liang; Si-Si Ma; Yi-Jing Li; Xing-Jie Ping; Ling Hu; Cai-Lian Cui
Journal:  Neurochem Res       Date:  2012-03-07       Impact factor: 3.996

9.  Cocaine locomotor activation, sensitization and place preference in six inbred strains of mice.

Authors:  Amy F Eisener-Dorman; Laura Grabowski-Boase; Lisa M Tarantino
Journal:  Behav Brain Funct       Date:  2011-08-01       Impact factor: 3.759

10.  The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study.

Authors:  Teresa R Franklin; Derek Harper; Kyle Kampman; Susan Kildea-McCrea; Will Jens; Kevin G Lynch; Charles P O'Brien; Anna Rose Childress
Journal:  Drug Alcohol Depend       Date:  2009-04-23       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.